| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/17/2009 | US20090234004 Pharmaceutical compositions having desirable bioavailability |
| 09/17/2009 | US20090234003 Carbamate compounds for use in preventing or treating anxiety disorders |
| 09/17/2009 | US20090234002 Abuse-resistant amphetamine prodrugs |
| 09/17/2009 | US20090234001 Vitamin d receptor modulators |
| 09/17/2009 | US20090234000 Triptolide Analogs for the Treatment of Autoimmune and Inflammatory Disorders |
| 09/17/2009 | US20090233999 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 09/17/2009 | US20090233998 Desmosdumotins, the Method for Preparing the Same and Use as Anti-Tumor or Anti-AIDS Agents |
| 09/17/2009 | US20090233997 Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same |
| 09/17/2009 | US20090233996 Avermectin/benzoyl peroxide compositions for treating afflictions of the skin, e.g., rosacea |
| 09/17/2009 | US20090233995 Use of drug combinations for treating insulin resistance |
| 09/17/2009 | US20090233994 Novel Glutamic Acid Decarboxylase (GAD) Chimera And Methods Of Use |
| 09/17/2009 | US20090233993 Compositions and methods for inhibiting gsk3 activity and uses thereof |
| 09/17/2009 | US20090233992 Hepatitis c virus vaccine |
| 09/17/2009 | US20090233991 Generation of biological pacemaker activity |
| 09/17/2009 | US20090233990 Generation of biological pacemaker activity |
| 09/17/2009 | US20090233989 Oligonucleotides stimulatory of the mesenchymal stem cell proliferation and uses thereof |
| 09/17/2009 | US20090233988 Therapeutic Agents for Diseases Associated With Apoptotic Degeneration in Ocular Tissue Cells That Use SIV-PEDF Vectors |
| 09/17/2009 | US20090233987 Method and apparatus for drug delivery to tissue or organ for transplant |
| 09/17/2009 | US20090233986 Methods and compositions for using sax2 |
| 09/17/2009 | US20090233985 Compositions and methods for inhibiting hiv infections by inhibiting lerepo4 and glipr |
| 09/17/2009 | US20090233984 RNAi Modulation of RSV and Therapeutic Uses Thereof |
| 09/17/2009 | US20090233982 Methyltransferases and Their Uses |
| 09/17/2009 | US20090233981 Compounds for Hydrolyzing Ribonucleic Acids (RNA's) |
| 09/17/2009 | US20090233980 Substituted gamma lactams as therapeutic agents |
| 09/17/2009 | US20090233979 Indole Derivatives and Their Use as Thyroid Receptor Ligands |
| 09/17/2009 | US20090233978 Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders |
| 09/17/2009 | US20090233977 Method of Treating Atherosclerosis, dyslipidemias and related conditions |
| 09/17/2009 | US20090233976 Antimitotic Rhizoxin Deritivatives of Burkholderia Rhizoxina, Method for Producing Said Derivatives and Use Thereof |
| 09/17/2009 | US20090233975 Hair resiliency/body improver and hair cosmetic |
| 09/17/2009 | US20090233974 Substituted gamma lactams as therapeutic agents |
| 09/17/2009 | US20090233973 Epothilone derivatives for the treatment of multiple myeloma |
| 09/17/2009 | US20090233972 Substituted heterocycles as anti-infectives |
| 09/17/2009 | US20090233971 GSK-3 Inhibitors |
| 09/17/2009 | US20090233970 Combined nsaid and acid blocker formulation and method |
| 09/17/2009 | US20090233969 Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammation |
| 09/17/2009 | US20090233968 INHIBITORS OF THE ALPHA2BETA1/GPIa-IIA INTEGRIN |
| 09/17/2009 | US20090233967 Crystalline forms of mc4r agonist and process for synthesis |
| 09/17/2009 | US20090233966 Analogues of the Azinomycins as Anti-Tumour Agents and as Prodrugs |
| 09/17/2009 | US20090233965 Alkyl Esters Of Cyclic Amino Alcohols With Muscarinic M3 Receptor Antagonist Activity, Useful For Treating E.G. Chronic Bronchial Obstruction, Asthma And Overactive Bladder |
| 09/17/2009 | US20090233964 Methods for improving the pharmacokinetics of hiv integrase inhibitors |
| 09/17/2009 | US20090233963 Methods to determine suceptibility to treatment with leukotriene modifiers |
| 09/17/2009 | US20090233961 Tartrate derivatives for use as coagulation factor ixa inhibitors |
| 09/17/2009 | US20090233960 Kinase Inhibitors |
| 09/17/2009 | US20090233959 Beloxepin and analogs for the treatment of pain |
| 09/17/2009 | US20090233958 (+)-beloxepin and methods for its synthesis and use |
| 09/17/2009 | US20090233957 (-)-beloxepin and methods for its synthesis and use |
| 09/17/2009 | US20090233956 NOVEL PYRROLO(2,3-b) PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS |
| 09/17/2009 | US20090233955 1H-Pyrrolo[2,3-B]Pyridnes |
| 09/17/2009 | US20090233954 Methods and systems for prognosis of a patient's response to treatment of androgenetic skin disorders |
| 09/17/2009 | US20090233953 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 09/17/2009 | US20090233952 Substituted cycloalkene derivative |
| 09/17/2009 | US20090233951 Parenteral solutions containing metolazone |
| 09/17/2009 | US20090233950 Quinazoline derivatives |
| 09/17/2009 | US20090233949 Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 09/17/2009 | US20090233948 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 09/17/2009 | US20090233947 2,3-Substituted fused bicyclic pyrimidin-4(3H)-ones which modulating the function of the vanilloid -1 receptor (VR1) |
| 09/17/2009 | US20090233946 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation |
| 09/17/2009 | US20090233945 New compounds 834 |
| 09/17/2009 | US20090233944 Pyrazine-2-carboxyamide derivatives |
| 09/17/2009 | US20090233943 New compounds 835 |
| 09/17/2009 | US20090233942 Genetic markers associated with response to antidepressants |
| 09/17/2009 | US20090233941 Co-Crystals of Calixarenes and Biologically Active Molecules |
| 09/17/2009 | US20090233939 Treatment of amm |
| 09/17/2009 | US20090233938 Thiazole derivatives as a2b antagonists |
| 09/17/2009 | US20090233937 Fused heterocyclic compound |
| 09/17/2009 | US20090233936 Fused Aminopiperidines as Dipeptidyl Peptidase-4 Inhibitors for the Treatment or Prevention of Diabetes |
| 09/17/2009 | US20090233935 Methods for Fabrication of Antimicrobial Surfaces |
| 09/17/2009 | US20090233933 Prostaglandin Transporter Inhibitors |
| 09/17/2009 | US20090233932 Novel crystalline forms of lamotrigine |
| 09/17/2009 | US20090233931 Therapeutic compounds |
| 09/17/2009 | US20090233930 Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia |
| 09/17/2009 | US20090233929 Imidazole Derivatives for the Treatment of Anxiety and Related Diseases |
| 09/17/2009 | US20090233928 Imidazolo-5-yl-2-anilo-pyrimidines as agents for the inhibition of cell proliferation |
| 09/17/2009 | US20090233927 2-aminoquinolines |
| 09/17/2009 | US20090233926 2-benzimidazolyl-6-morpholino-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 09/17/2009 | US20090233925 Hepatitis C Virus Inhibitors |
| 09/17/2009 | US20090233924 Quinazoline derivatives |
| 09/17/2009 | US20090233923 Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof |
| 09/17/2009 | US20090233922 Method for Treating Neuronal and Non-Neuronal Pain |
| 09/17/2009 | US20090233921 Therapeutic cyclopentane derivatives |
| 09/17/2009 | US20090233920 Organic compounds |
| 09/17/2009 | US20090233919 Thiazolopyridinone derivates as mch receptor antagonists |
| 09/17/2009 | US20090233918 2-(cyclic amino)-pyrimidone derivatives |
| 09/17/2009 | US20090233917 Stroke recovery |
| 09/17/2009 | US20090233915 mitogen-activated protein kinase inhibitors such as 3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-N-(2-hydroxy-ethoxy)-5(2-hydroxy-ethoxymethyl)-benzamide, used to treat proliferative diseases, for example, cancers, psoriasis, restenosis, autoimmune diseases and atherosclerosis |
| 09/17/2009 | US20090233914 Composition for treatment of nail infections |
| 09/17/2009 | US20090233913 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis |
| 09/17/2009 | US20090233912 Non-aqueous pharmaceutical composition |
| 09/17/2009 | US20090233911 Thiadiazole derivatives for the treatment of neurodegenerative diseases |
| 09/17/2009 | US20090233910 Npy antagonists, preparation and uses |
| 09/17/2009 | US20090233909 Sulfonamide compounds as cysteine protease inhibitors |
| 09/17/2009 | US20090233908 Nitrogenous heterocyclic compound and medicinal use thereof |
| 09/17/2009 | US20090233907 Pyridopyrimidine Derivatives and Their Use as PDE4 Inhibitors |
| 09/17/2009 | US20090233906 Imidazoazepinone compounds |
| 09/17/2009 | US20090233905 Combinations comprising bcr-abl/c-kit/pdgf-r tk inhibitors for treating cancer |
| 09/17/2009 | US20090233904 Macrocyclic Spiro Pyrimidine Derivatives |
| 09/17/2009 | US20090233903 Azetidine and cyclobutane derivatives as jak inhibitors |
| 09/17/2009 | US20090233902 Indolopyridines as eg5 kinesin modulators |
| 09/17/2009 | US20090233901 Vla-4 inhibitory drug |
| 09/17/2009 | US20090233900 2-aminobenzamide derivative |